2015 annual financial data
Vistagen Therapeutics 2015 Operating margin
Direct answer
Operating margin was 5,020.07%.
Operating income was -6,777,100 USD and net income was -13,885,800 USD.
Operating cash flow was -2,768,900 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -135,000 USD
- Operating income
- -6,777,100 USD
- Net income
- -13,885,800 USD
- Operating cash flow
- -2,768,900 USD